Sepsis Care Guided by Daily Procalcitonin Cuts Antibiotic Duration
By Lori Solomon HealthDay Reporter
MONDAY, Dec. 16, 2024 -- Sepsis care guided by measurement of procalcitonin (PCT) reduces antibiotic duration safely compared with standard care, according to a study published online Dec. 9 in the Journal of the American Medical Association to coincide with the Critical Care Reviews Down Under meeting, held from Dec. 10 to 11 in Melbourne, Australia.
Paul Dark, M.D., Ph.D., from the University of Manchester in the United Kingdom, and colleagues assessed whether decisions based on assessment of C-reactive protein (CRP) or PCT safely results in a reduction in the duration of antibiotic therapy. The analysis included 2,760 critically ill adults with suspected sepsis requiring critical care (41 units) within 24 hours of initiating intravenous antibiotics for suspected sepsis and likely to continue antibiotics for at least 72 hours. Patients were assigned to the daily PCT-guided protocol (918 patients), the daily CRP-guided protocol (924 patients), or standard care (918 patients).
The researchers found a significant reduction in antibiotic duration from random assignment to 28 days for those in the daily PCT-guided protocol versus standard care (mean duration, 10.7 days for standard care and 9.8 days for PCT). The daily PCT-guided protocol was noninferior to standard care for all-cause mortality up to 28 days, where the noninferiority margin was set at 5.4 percent (19.4 percent for standard care; 20.9 percent for PCT). Compared with standard care, there was no difference in antibiotic duration for the daily CRP-guided protocol (mean duration, 10.6 days for CRP). Inconclusive results were seen for all-cause mortality with the daily CRP-guided protocol compared with standard care (21.1 percent for CRP; absolute difference, 1.69).
"It is likely that the differential clinical effectiveness findings for daily PCT-guided and daily CRP-guided protocols are explained by the differences in the utility of these biomarkers to track inflammation caused by bacterial infection in the setting of critical illness, where PCT concentrations are known to increase earlier and normalize more rapidly than CRP in response to treatment," the authors write.
Several authors disclosed ties to the pharmaceutical and biotechnology industries.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-12-17 06:00
Read more
- Psychologists' Group Issues First Guidance to Parents on Teen Online Video Use
- Study Looks at Impact of Children's Exposure to Lead in the United States
- Taxi Drivers' Brains May Leave Them Less Vulnerable to Alzheimer's
- Could a Vitamin Be Effective Treatment for COPD?
- Bribing Kids With Holiday Gifts Popular With Parents, Poll Says
- Merck Provides Update on KeyVibe and KEYFORM Clinical Development Programs Evaluating Investigational Vibostolimab and Favezelimab Fixed-Dose Combinations with Pembrolizumab
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions